Your Article Summary
Intradermal Versus Intramuscular Hepatitis B Vaccination in Hemodialysis Patients: A Prospective Open-Label Randomized Controlled Trial in Nonresponders to Primary Vaccination
American Journal of Kidney Diseases, 06/02/09
Barraclough KA et al. - Significantly greater seroconversion rates and peak antibody titers can be achieved with ID compared with IM vaccination in hemodialysis patients nonresponsive to primary vaccination. ID vaccination should become the standard of care in this setting.
Related Articles
Psoas abscess in hemodialysis patients
International Urology and Nephrology, 10/06/09
Relevance Score: 90%
Improved Nutrition After Conversion to Nocturnal Home Hemodialysis
Journal of Renal Nutrition, 10/14/09
Relevance Score: 89%
Permanent Hearing Loss With Iopamidol Following Aortic Angiography in a Hemodialysis Patient: A Case Report and Review of the Literature
American Journal of Kidney Diseases, 10/28/09
Relevance Score: 87%
Prevalence and Cardiovascular Features of Japanese Hemodialysis Patients with Fabry Disease
American Journal of Nephrology, 10/16/09
Relevance Score: 87%
Revised Dyadic Adjustment Scale as a Reliable Tool for Assessment of Quality of Marital Relationship in Patients on Long-Term Hemodialysis
Iranian Journal of Kidney Diseases, 10/13/09
Relevance Score: 87%
Today in Hepatitis...keeping you current
Receive free subspecialty "5-minute updates" via email
Hepatitis C progressing to hepatocellular carcinoma: the HCV dialysis patient in dilemma
Journal of Viral Hepatitis, 12/17/09
Naturally occurring amino–acid substitutions to nucleos(t)ide analogues in treatment naive Turkish patients with chronic hepatitis B
Journal of Viral Hepatitis, 12/17/09
Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B
Journal of Viral Hepatitis, 12/17/09
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
New England Journal of Medicine, 12/17/09
A Novel Influenza A (H1N1) Vaccine in Various Age Groups
New England Journal of Medicine, 12/17/09
Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
New England Journal of Medicine, 12/17/09

See Latest Articles